The virulence polysaccharide vi released by Salmonella Typhi targets membrane prohibitin to inhibit T-cell activation

Journal of Infectious Diseases

Volumn 210, Issue 1, 2014, Pages 79-88

  Santhanam, Srikanth K ^a   Dutta, Debjani ^b   Parween, Farhat ^a   Qadri, Ayub ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Prohibitin; Salmonella typhi; T cells; Virulence polysaccharide Vi

Indexed keywords

ACTIN; BACTERIAL POLYSACCHARIDE; CD3 ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE; PROHIBITIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; VIRULENCE FACTOR; VIRULENCE POLYSACCHARIDE VI;

ACTIN POLYMERIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARBOHYDRATE TRANSPORT; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN TARGETING; RECEPTOR DOWN REGULATION; SALMONELLA TYPHI; SEROTYPE; T LYMPHOCYTE ACTIVATION; TYPHOID FEVER;

ANIMALS; CELL MEMBRANE; CELLS, CULTURED; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; POLYSACCHARIDES, BACTERIAL; REPRESSOR PROTEINS; SALMONELLA TYPHI; T-LYMPHOCYTES;

EID: 84897379559     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu064     Document Type: Article

References (28)

1. Ruby T, McLaughlin L, Gopinath S, Monack D. Salmonella's long-term relationship with its host. FEMS Microbiol Rev 2012; 36:600-15.
2. Bhan MK, Bahl R, Bhatnagar S. Typhoid and paratyphoid fever. Lancet 2005; 366:749-62.
3. Jones BD, Falkow S. Salmonellosis: host immune responses and bacterial virulence determinants. Annu Rev Immunol 1996; 14:533-61.
4. + TCRαβ cells and IFN-γ in bacterial clearance independent of intracellular location. J Immunol 1996; 156:3321-6.
5. Lalmanach AC, Lantier F. Host cytokine response and resistance to Salmonella infection. Microbes Infect 1999; 1:719-26.
6. Pie S, Truffa-Bachi P, Pla M, Nauciel C. Th1 response in Salmonella typhimurium-infected mice with a high or low rate of bacterial clearance. Infect Immun 1997; 65:4509-14.
7. Monack DM, Bouley DM, Falkow S. Salmonella typhimurium persists within macrophages in the mesenteric lymph nodes of chronically infected Nramp1+/+ mice and can be reactivated by IFNgamma neutralization. J Exp Med 2004; 199:231-41.
8. Sztein MB. Cell-mediated immunity and antibody responses elicited by attenuated Salmonella enterica Serovar Typhi strains used as live oral vaccines in humans. Clin Infect Dis 2007; 1:S15-9.
9. Felix A, Pitt RM. Virulence and immunogenic activities of B. typhosus in relation to its antigenic constituents. J Hyg (Lond) 1935; 35:428-36.
10. Wilson RP, Winter SE, Spees AM, et al. The Vi capsular polysaccharide prevents complement receptor 3-mediated clearance of Salmonella enterica serotype Typhi. Infect Immun 2011; 79:830-7.
11. Sharma A, Qadri A. Vi polysaccharide of Salmonella typhi targets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses. Proc Natl Acad Sci U S A 2004; 101:17492-7.
12. Garg R, Qadri A. Hemoglobin transforms anti-inflammatory Salmonella typhi virulence polysaccharide into a TLR-2 agonist. J Immunol 2010; 184:5980-7.
13. Mishra S, Murphy LC, Nyomba BL, Murphy LJ. Prohibitin: a potential target for new therapeutics. Trends Mol Med 2005; 11:192-7.
14. Morrow IC, Parton RG. Flotillins and the PHB domain protein family: rafts, worms and anaesthetics. Traffic 2005; 6:725-40.
15. Osman C, Merkwirth C, Langer T. Prohibitins and the functional compartmentalization of mitochondrial membranes. J Cell Sci 2009; 122: 3823-30.
16. Terashima M, Kim KM, Adachi T, et al. The IgM antigen receptor of B lymphocytes is associated with prohibitin and a prohibitin-related protein. EMBO J 1994; 13:3782-92.
17. Rajalingam K, Wunder C, Brinkmann V, et al. Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. Nat Cell Biol 2005; 7:837-43.
18. Barda-Saad M, Braiman A, Titerence R, Bunnell SC, Barr VA, Samelson LE. Dynamic molecular interactions linking the T cell antigen receptor to the actin cytoskeleton. Nat Immunol 2005; 6:80-9.
19. Young D, Hussell T, Dougan G. Chronic bacterial infections: living with unwanted guests. Nat Immunol 2002; 3:1026-32.
20. Barrett TJ, Snyder JD, Blake PA, Feeley JC. Enzyme-linked immunosorbent assay for detection of Salmonella typhi Vi antigen in urine from typhoid patients. J Clin Microbiol 1982; 15:235-7.
21. Pandya M, Pillai P, Deb M. Rapid diagnosis of typhoid fever by detection of Barber protein and Vi antigen of Salmonella serotype typhi. J Med Microbiol 1995; 43:185-8.
22. Kullas AL, McClelland M, Yang HJ, et al. L-asparaginase II produced by Salmonella typhimurium inhibits T cell responses and mediates virulence. Cell Host Microbe 2012; 12:791-8.
23. Campi G, Varma R, Dustin ML. Actin and agonist MHC-peptide complex dependent T cell receptor microclusters as scaffolds for signaling. J Exp Med 2005; 202:1031-6.
24. Salmond RJ, Filby A, Qureshi I, Caserta S, Zamoyska R. T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T cell activation, differentiation, and tolerance. Immunol Rev 2009; 228:9-22.
25. Lauritsen JP, Christensen MD, Dietrich J, Kastrup J, Odum N, Geisler C. Two distinct pathways exist for down-regulation of the TCR. J Immunol 1998; 161:260-7.
26. Anderson DL, Tsoukas CD. Cholera toxin inhibits resting human T cell activation via a cAMP-independent pathway. J Immunol 1989; 143: 3647-52.
27. Coates PJ, Jamieson DJ, Smart K, Prescott AR, Hall PA. The prohibitin family of mitochondrial proteins regulate replicative lifespan. Curr Biol 1997; 7:607-10.
28. Szewczyk B, Taylor A. Immunochemical properties of Vi antigen from Salmonella typhi Ty2: presence of two antigenic determinants. Infect Immun 1980; 29:539-44.